Literature DB >> 26848484

What Are the Recommended Timing and Screening Modalities in Women at Higher Risk for Developing Breast Cancer? A Clin-IQ.

Summer Jatala1, Shawn Fitzgerald1, Pamela Tietze1, Kalyanakrishnan Ramakrishnan1, Laine H McCarthy1, Elizabeth Wickersham1.   

Abstract

Early detection of breast cancer is desirable to prevent progression to advanced disease. This subject has been one of significant study and debate for women at normal risk, and recommendations continue to evolve. However, with regard to women at high risk, the recommendations from various health care professional organizations, including the recent recommendations from the United States Preventative Services Task Force, are different and also inconsistent concerning when to begin screening and which modalities should be used. We review several randomized controlled trials and consensus opinions regarding when to begin screening for breast cancer and how to best screen women at high risk. Specifically, we address women with known personal history of breast cancer, prior mantle radiation, or specific family history (including genetic family history) of breast cancer. The purpose of this inquiry is to present current evidence and suggest a clinical pathway regarding the screening of women at high risk for breast cancer.

Entities:  

Keywords:  breast cancer; magnetic resonance imaging; mammography; risk factors for breast cancer; screening for breast cancer; screening modalities for breast cancer; women over 18 years of age

Year:  2015        PMID: 26848484      PMCID: PMC4737590          DOI: 10.17294/2330-0698.1051

Source DB:  PubMed          Journal:  J Patient Cent Res Rev        ISSN: 2330-068X


  11 in total

Review 1.  Clinical practice. Mammographic screening for breast cancer.

Authors:  Suzanne W Fletcher; Joann G Elmore
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

2.  Mammographic screening for breast cancer.

Authors:  William A Hensel
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

3.  Mammogram debate flares up: Latest breast cancer screening study fuels controversy.

Authors:  Carrie Printz
Journal:  Cancer       Date:  2014-06-15       Impact factor: 6.860

4.  Performance of screening mammography among women with and without a first-degree relative with breast cancer.

Authors:  K Kerlikowske; P A Carney; B Geller; M T Mandelson; S H Taplin; K Malvin; V Ernster; N Urban; G Cutter; R Rosenberg; R Ballard-Barbash
Journal:  Ann Intern Med       Date:  2000-12-05       Impact factor: 25.391

5.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

Authors:  M O Leach; C R M Boggis; A K Dixon; D F Easton; R A Eeles; D G R Evans; F J Gilbert; I Griebsch; R J C Hoff; P Kessar; S R Lakhani; S M Moss; A Nerurkar; A R Padhani; L J Pointon; D Thompson; R M L Warren
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

6.  Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.

Authors:  Andrew Maurice; D Gareth Evans; Jenny Affen; Rosemary Greenhalgh; Stephen W Duffy; Anthony Howell
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

7.  Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.

Authors:  Carol H Lee; D David Dershaw; Daniel Kopans; Phil Evans; Barbara Monsees; Debra Monticciolo; R James Brenner; Lawrence Bassett; Wendie Berg; Stephen Feig; Edward Hendrick; Ellen Mendelson; Carl D'Orsi; Edward Sickles; Linda Warren Burhenne
Journal:  J Am Coll Radiol       Date:  2010-01       Impact factor: 5.532

8.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

9.  Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.

Authors:  C H Ahern; Y-C T Shih; W Dong; G Parmigiani; Y Shen
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

10.  Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Authors:  Anthony B Miller; Claus Wall; Cornelia J Baines; Ping Sun; Teresa To; Steven A Narod
Journal:  BMJ       Date:  2014-02-11
View more
  1 in total

1.  Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50.

Authors:  Ilan Gielchinsky; Matthijs J Scheltema; Thomas Cusick; John Chang; Ron Shnier; Daniel Moses; Warick Delprado; Quoc Nguyen; Carlo Yuen; Anne-Maree Haynes; Phillip D Stricker
Journal:  Res Rep Urol       Date:  2018-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.